New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BriaCell Therapeutics Corp.
BCTX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

31M

Biotechnology

Next Earning date - 30 Oct 2024

31M

Biotechnology

Next Earning date - 30 Oct 2024

0.87USD
Shape-0.02 ( -2.58%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-89%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

85%

Quote Panel

Shape
Updated October 28, 2024
1W -0.60 % 1M -30.08 % 3M 17.64 % 1Y -78.33 %

Key Metrics

Shape
  • Market Cap

    31.07M


  • Shares Outstanding

    35.84M


  • Share in Float

    31.59M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    0.867


  • Average Volume

    4.85M


  • Beta

    1.834


  • Range

    0.46-5.97


  • Industry

    Biotechnology


  • Website

    https://www.briacell.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

-2.33x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.4

EPS

How BCTX compares to sector?

P/E Ratio

Relative Strength

Shape

BCTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.79

Shape-819%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.32
vs -0.93

Q3.22

arrow
arrow

N/A

-1.01
vs 0.05

Q4.22

arrow
arrow

N/A

-0.07
vs -0.15

Q1.23

arrow
arrow

N/A

-0.77
vs -0.24

Q2.23

arrow
arrow

N/A

-0.32
vs -0.32

Q3.23

arrow
arrow

N/A

-0.15
vs -1.01

Q4.23

arrow
arrow

N/A

-0.50
vs -0.07

Q1.24

arrow
arrow

N/A

-0.71
vs -0.77

Q2.24

arrow
arrow

+134%

0.11
vs -0.32

Q3.24

arrow
arrow

N/A

-0.71
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-170%

-1.70
vs -0.20

Q4.22

arrow
arrow

+31%

0.31
vs -1.70

Q1.23

arrow
arrow

+928%

9.28
vs 0.31

Q2.23

arrow
arrow

+74%

0.74
vs 9.28

Q3.23

arrow
arrow

+64%

0.64
vs 0.74

Q4.23

arrow
arrow

+221%

2.21
vs 0.64

Q1.24

arrow
arrow

+142%

1.42
vs 2.21

Q2.24

arrow
arrow

-29%

-0.29
vs 1.42

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

28

28
vs 24

17%

Q3.22

arrow
arrow

28

28
vs 28

NA

Q4.22

arrow
arrow

24

24
vs 28

-14%

Q1.23

arrow
arrow

24

24
vs 24

NA

Q2.23

arrow
arrow

25

25
vs 24

4%

Q3.23

arrow
arrow

2

2
vs 25

-92%

Q4.23

arrow
arrow

2

2
vs 2

NA

Q1.24

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News